These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36718661)

  • 1. Puerarin Suppresses Glycolysis and Increases Cisplatin Chemosensitivity in Oral Squamous Cell Carcinoma
    Cai Y; Gao Q; Meng JH; Chen L
    Nutr Cancer; 2023; 75(3):1028-1037. PubMed ID: 36718661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
    Zhang P; Shao Y; Quan F; Liu L; Yang J
    Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXW7 Enhances Cisplatin-Induced Apoptosis in Oral Cancer Cell Lines.
    Yang Q; Sun Y; Qiu B; Zhao H
    Int Dent J; 2023 Oct; 73(5):620-627. PubMed ID: 36481094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma.
    Qiu B; Sun Y; Nie W; Yang Q; Guo X
    Immun Inflamm Dis; 2023 May; 11(5):e845. PubMed ID: 37249289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin acts via the G3BP1/YWHAZ axis to inhibit glycolysis and proliferation in oral squamous cell carcinoma.
    Hu M; Song HY; Chen L
    Toxicol Mech Methods; 2023 Feb; 33(2):141-150. PubMed ID: 35945655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
    Long W; Gong X; Yang Y; Yang K
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXW7 affects autophagy through MCL1 in oral squamous cell carcinoma.
    Sun Y; Nie W; Qiu B; Yang Q; Zhao H
    Oral Dis; 2023 Nov; 29(8):3259-3267. PubMed ID: 38055341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
    Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
    Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway.
    Pai S; Yadav VK; Kuo KT; Pikatan NW; Lin CS; Chien MH; Lee WH; Hsiao M; Chiu SC; Yeh CT; Tsai JT
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768921
    [No Abstract]   [Full Text] [Related]  

  • 12. TIMELESS promotes reprogramming of glucose metabolism in oral squamous cell carcinoma.
    Chen Y; Han Z; Zhang L; Gao C; Wei J; Yang X; Han Y; Li Y; Zhang C; Wei Y; Dong J; Xun W; Sun W; Zhang T; Zhang H; Chen J; Yuan P
    J Transl Med; 2024 Jan; 22(1):21. PubMed ID: 38178094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PER2 binding to PDK1 enhances the cisplatin sensitivity of oral squamous cell carcinoma through inhibition of the AKT/mTOR pathway.
    Zheng H; Yu W; Ren J; Tang H; Li H; Zhang Z; Yin S; Yang K
    Cell Signal; 2024 Oct; 122():111327. PubMed ID: 39079621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STYX/FBXW7 axis participates in the development of endometrial cancer cell via Notch-mTOR signaling pathway.
    Liu L; Jiang H; Wang X; Wang X; Zou L
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32239181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway.
    Sun Y; Chen Y; Xu M; Liu C; Shang H; Wang C
    Biomed Res Int; 2020; 2020():9243681. PubMed ID: 32685545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
    Lu H; Yao B; Wen X; Jia B
    BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑223‑induced inhibition of the
    Liu Z; Ma T; Duan J; Liu X; Liu L
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.
    Coppock JD; Wieking BG; Molinolo AA; Gutkind JS; Miskimins WK; Lee JH
    Neoplasia; 2013 Jun; 15(6):620-30. PubMed ID: 23730210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.